99 related articles for article (PubMed ID: 24136278)
1. [Association factors analysis of diarrhea in patients receiving kidney transplantation].
Sun W; Guo HB; Xie ZL; Zhang L; Tian Y; Lin J
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Oct; 45(5):779-81. PubMed ID: 24136278
[TBL] [Abstract][Full Text] [Related]
2. Late, severe, noninfectious diarrhea after renal transplantation: high-risk factors, therapy, and prognosis.
Zhao YJ; Wen JQ; Cheng K; Ming YZ; She XG; Liu H; Liu L; Ye QF; Ding BN
Transplant Proc; 2013; 45(6):2226-32. PubMed ID: 23953533
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between dose of mycophenolate mofetil and the occurrence of cytomegalovirus infection and diarrhea in renal transplant recipients].
Toda T; Motoki T; Kurosawa N; Owada E; Achiwa K; Yuhki Y; Tadano K; Takahashi Y; Shimoda N; Shindo J; Harada H; Seki T; Hirano T
Yakugaku Zasshi; 2005 Feb; 125(2):177-85. PubMed ID: 15684572
[TBL] [Abstract][Full Text] [Related]
4. Impact of type of calcineurin inhibitor on post-transplant tuberculosis: Single-center study from India.
Agarwal SK; Bhowmik D; Mahajan S; Bagchi S
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27775825
[TBL] [Abstract][Full Text] [Related]
5. Infections in renal transplant recipients receiving mycophenolate versus azathioprine-based immunosuppression.
Bernabeu-Wittel M; Naranjo M; Cisneros JM; Cañas E; Gentil MA; Algarra G; Pereira P; González-Roncero FJ; de Alarcón A; Pachón J
Eur J Clin Microbiol Infect Dis; 2002 Mar; 21(3):173-80. PubMed ID: 11957018
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporine, tacrolimus and sirolimus retain their distinct toxicity profiles despite low doses in the Symphony study.
Ekberg H; Bernasconi C; Nöldeke J; Yussim A; Mjörnstedt L; Erken U; Ketteler M; Navrátil P
Nephrol Dial Transplant; 2010 Jun; 25(6):2004-10. PubMed ID: 20106825
[TBL] [Abstract][Full Text] [Related]
7. Intestinal infection at onset of mycophenolic acid-associated chronic diarrhea in kidney transplant recipients.
von Moos S; Cippà PE; Wüthrich RP; Mueller TF
Transpl Infect Dis; 2016 Oct; 18(5):721-729. PubMed ID: 27502733
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of diabetes mellitus in patients after renal transplantation].
Wyzgał J; Paczek L; Senatorski G; Pilecki T; Gradowska L; Zegarska J
Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():16-9; discussion 19-20. PubMed ID: 12621776
[TBL] [Abstract][Full Text] [Related]
9. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.
Grinyó JM; Gil-Vernet S; Cruzado JM; Caldés A; Riera L; Serón D; Rama I; Torras J
Transpl Int; 2003 Nov; 16(11):820-7. PubMed ID: 12879230
[TBL] [Abstract][Full Text] [Related]
10. Etiologic agents of diarrhea in solid organ recipients.
Arslan H; Inci EK; Azap OK; Karakayali H; Torgay A; Haberal M
Transpl Infect Dis; 2007 Dec; 9(4):270-5. PubMed ID: 17511817
[TBL] [Abstract][Full Text] [Related]
11. Cancer Screening of Renal Transplant Patients Undergoing Long-Term Immunosuppressive Therapy.
Demir T; Ozel L; Gökçe AM; Ata P; Kara M; Eriş C; Özdemir E; Titiz MI
Transplant Proc; 2015 Jun; 47(5):1413-7. PubMed ID: 26093731
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and interventional strategies for BK polyomavirus infection after renal transplantation.
Steubl D; Baumann M; Schuster T; Fischereder M; Krämer BK; Heemann U; Lutz J
Scand J Urol Nephrol; 2012 Dec; 46(6):466-74. PubMed ID: 23016678
[TBL] [Abstract][Full Text] [Related]
13. A Prospective Randomized, Comparative Trial of High-Dose Mizoribine Versus Mycophenolate Mofetil in Combination With Tacrolimus and Basiliximab for Living Donor Renal Transplant: A Multicenter Trial.
Ishida H; Takahara S; Amada N; Tomikawa S; Chikaraishi T; Takahashi K; Uchida K; Akiyama T; Tanabe K; Toma H;
Exp Clin Transplant; 2016 Oct; 14(5):518-525. PubMed ID: 27733107
[TBL] [Abstract][Full Text] [Related]
14. Tolerance of enteric-coated mycophenolate sodium in combination with calcineurin inhibitor in kidney transplant recipients: Polish experience.
Gozdowska J; Urbanowicz AL; Galazka Z; Chmura A; Durlik M
Transplant Proc; 2011 Oct; 43(8):2946-9. PubMed ID: 21996197
[TBL] [Abstract][Full Text] [Related]
15. Diarrhea in kidney transplant recipients: Etiology and outcome.
Sonambekar A; Mehta V; Desai D; Abraham P; Almeida A; Joshi A; Gupta T; Sirsat R; Kothari J
Indian J Gastroenterol; 2020 Apr; 39(2):141-146. PubMed ID: 32350724
[TBL] [Abstract][Full Text] [Related]
16. Late evolution of kidney transplants in elderly donors and recipients receiving initial immunosuppressant treatment with daclizumab, mycophenolate mofetil, and delayed introduction of tacrolimus.
González-Roncero FM; Gentil-Govantes MÁ; González-Molina M; Rivero M; Cantarell C; Alarcón A; Franco A; Sánchez-Plumed J; Lampreabe I; Lauzurica R; González E; Romero R; Ruiz-San Millán JC; Osuna A
Nefrologia; 2012 Jul; 32(4):446-54. PubMed ID: 22806279
[TBL] [Abstract][Full Text] [Related]
17. CMV infections after two doses of daclizumab versus thymoglobulin in renal transplant patients receiving mycophenolate mofetil, steroids and delayed cyclosporine A.
Abou-Ayache R; Büchler M; Lepogamp P; Westeel PF; Le Meur Y; Etienne I; Lobbedez T; Toupance O; Caillard S; Goujon JM; Bergougnoux L; Touchard G
Nephrol Dial Transplant; 2008 Jun; 23(6):2024-32. PubMed ID: 18199693
[TBL] [Abstract][Full Text] [Related]
18. Quadruple immunosuppression with basiliximab, tacrolimus, mycophenolate mofetil and prednisone is safe and effective for renal transplantation.
Miura M; Harada H; Fukuzawa N; Iwami D; Taniguchi A; Seki T; Togashi M; Ogawa Y; Satoh H; Hirano T
Clin Transplant; 2005; 19 Suppl 14():54-8. PubMed ID: 15955170
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplantation with tacrolimus and steroid avoidance: four-year analysis.
Ciancio G; Gaynor JJ; Zarak A; Sageshima J; Guerra G; Roth D; Brown R; Kupin W; Chen L; Tueros L; Hanson L; Ruiz P; Burke GW
Transplantation; 2011 Jun; 91(11):1198-205. PubMed ID: 21107305
[TBL] [Abstract][Full Text] [Related]
20. Changes in the small bowel of symptomatic kidney transplant recipients converted from mycophenolate mofetil to enteric-coated mycophenolate sodium.
Bunnapradist S; Sampaio MS; Wilkinson AH; Pham PT; Huang E; Kuo HT; Anastasi B; Danovitch GM; Lo SK
Am J Nephrol; 2014; 40(2):184-90. PubMed ID: 25196230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
